SDGR Quote, Financials, Valuation and Earnings

Simulations Plus has a net margin of -108.07% compared to Schrodinger's net margin of 16.92%. Schrodinger's return on equity of -34.83% beat Simulations Plus's return on equity of 5.55%.

Schrodinger has a consensus price target of $32.00, signalling upside risk potential of 62.19%. On the other hand Simulations Plus has an analysts' consensus of -- which suggests that it could grow by 76.37%. Given that Simulations Plus has higher upside potential than Schrodinger, analysts believe Simulations Plus is more attractive than Schrodinger.

Schrodinger has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Simulations Plus has a beta of 0.758, suggesting its less volatile than the S&P 500 by 24.231%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus offers a yield of 0.85% to investors and pays a quarterly dividend of $0.06 per share. Schrodinger pays -- of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Schrodinger quarterly revenues are $35.3M, which are larger than Simulations Plus quarterly revenues of $18.5M. Schrodinger's net income of -$38.1M is lower than Simulations Plus's net income of $3.1M. Notably, Schrodinger's price-to-earnings ratio is -- while Simulations Plus's PE ratio is 57.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.47x versus 8.23x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.

Veeva Systems has a net margin of -108.07% compared to Schrodinger's net margin of 26.57%. Schrodinger's return on equity of -34.83% beat Veeva Systems's return on equity of 13.54%.

Schrodinger has a consensus price target of $32.00, signalling upside risk potential of 62.19%. On the other hand Veeva Systems has an analysts' consensus of $268.70 which suggests that it could grow by 23.58%. Given that Schrodinger has higher upside potential than Veeva Systems, analysts believe Schrodinger is more attractive than Veeva Systems.

Schrodinger has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Veeva Systems has a beta of 0.821, suggesting its less volatile than the S&P 500 by 17.902%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veeva Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrodinger pays -- of its earnings as a dividend. Veeva Systems pays out -- of its earnings as a dividend.

Schrodinger quarterly revenues are $35.3M, which are smaller than Veeva Systems quarterly revenues of $699.2M. Schrodinger's net income of -$38.1M is lower than Veeva Systems's net income of $185.8M. Notably, Schrodinger's price-to-earnings ratio is -- while Veeva Systems's PE ratio is 53.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.47x versus 13.47x for Veeva Systems. Usually stocks with elevated PS ratios are considered overvalued.

Nano Mobile Healthcare has a net margin of -108.07% compared to Schrodinger's net margin of --. Schrodinger's return on equity of -34.83% beat Nano Mobile Healthcare's return on equity of --.

Schrodinger has a consensus price target of $32.00, signalling upside risk potential of 62.19%. On the other hand Nano Mobile Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Schrodinger has higher upside potential than Nano Mobile Healthcare, analysts believe Schrodinger is more attractive than Nano Mobile Healthcare.

Schrodinger has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nano Mobile Healthcare has a beta of -0.315, suggesting its less volatile than the S&P 500 by 131.476%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nano Mobile Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrodinger pays -- of its earnings as a dividend. Nano Mobile Healthcare pays out -- of its earnings as a dividend.

Schrodinger quarterly revenues are $35.3M, which are larger than Nano Mobile Healthcare quarterly revenues of --. Schrodinger's net income of -$38.1M is higher than Nano Mobile Healthcare's net income of --. Notably, Schrodinger's price-to-earnings ratio is -- while Nano Mobile Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.47x versus -- for Nano Mobile Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Xsovt Brands has a net margin of -108.07% compared to Schrodinger's net margin of --. Schrodinger's return on equity of -34.83% beat Xsovt Brands's return on equity of --.

Schrodinger has a consensus price target of $32.00, signalling upside risk potential of 62.19%. On the other hand Xsovt Brands has an analysts' consensus of -- which suggests that it could fall by --. Given that Schrodinger has higher upside potential than Xsovt Brands, analysts believe Schrodinger is more attractive than Xsovt Brands.

Schrodinger has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xsovt Brands has a beta of 5.536, suggesting its more volatile than the S&P 500 by 453.568%.

Schrodinger has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xsovt Brands offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrodinger pays -- of its earnings as a dividend. Xsovt Brands pays out -- of its earnings as a dividend.

Schrodinger quarterly revenues are $35.3M, which are larger than Xsovt Brands quarterly revenues of --. Schrodinger's net income of -$38.1M is higher than Xsovt Brands's net income of --. Notably, Schrodinger's price-to-earnings ratio is -- while Xsovt Brands's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrodinger is 7.47x versus -- for Xsovt Brands. Usually stocks with elevated PS ratios are considered overvalued.